[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Becton, Dickinson and Company\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":83},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,40,65],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":25,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":39},"100635658","uk-purewick-at-home-pilot-study-100635658",false,"NCT07555548","UK PureWick™ At-Home Pilot Study","An Open-label Pilot Study Conducted in the UK to Evaluate the Clinical Benefits of the PureWick™ Female External Catheter System Compared to Indwelling Urinary Catheters in Female Patients Receiving Home-based Care","Inclusion Criteria:\n\n1. Adult Female Subjects \\>18 years of age at the time of signing the informed consent.\n2. Treated with indwelling catheters for at least four weeks\n3. Encountered \"problematic catheters\" necessitating a minimum of five interventions within the past month, involving medical treatment and HCP consultation;\n4. Willing to comply with all study procedures in this protocol\n5. The subject (or subject's power of attorney) must be willing and able to read, understand, sign, and date the informed consent form.\n\nExclusion Criteria:\n\nSubjects are excluded from the study if any of the following criteria apply:\n\n1. Has frequent episodes of bowel incontinence without a fecal management system in place; or\n2. Has moderate to heavy menstruation and cannot use a tampon or menstrual cup; or\n3. Has vaginal or other chronic non-urinary tract infections (UTIs), active genital herpes; or\n4. Is agitated, combative, and\u002For uncooperative and may remove the external catheter; or\n5. Has any wound, open lesion or irritation on the genitalia, perineum, or sacrum; or\n6. Has any pre-existing neurological, psychiatric, or other conditions that would confound quality of life assessment or would make it difficult to self-report on quality-of-life questionnaires in the opinion of the investigator; or\n7. Is known to be pregnant at time of enrollment (for women of childbearing age); or\n8. Has a confirmed diagnosis of urinary tract infection at the time of enrollment.\n9. Subjects with a urine output of ≥1800 mL over a 12-hour period who, or whose caregivers, are unable to independently empty the collection canister.\n10. Any other condition that, in the opinion of the investigator, would preclude them from participating in the study.","FEMALE","18 Years",{"count":19,"type":20},95,"ESTIMATED","OBSERVATIONAL","The UK PureWick™ At-Home Study is being carried out to see how well the PureWick™ Collection System works for women who use it at home instead of a traditional catheter. Traditional catheters are placed inside the body. The PureWick™ Collection System is different, it's placed outside the body .\n\nIn this study, researchers want to find out: how effective the PureWick™ Collection System is in helping women manage urine collection at home, whether patients prefer using PureWick™ Collection System over the usual catheter, how it affects their sleep, and overall well-being.The PureWick™ Collection System is intended for the treatment of patients who leak urine (called urine incontinence). The PureWick™ Collection System is designed to help manage urine in female patients without needing to insert a urinary catheter into the body.",[24],"Urinary Incontinence",[26],"UTI","RECRUITING","2026-07-10",{"date":30,"type":31},"2026-07-13","ACTUAL",{"date":33,"type":31},"2026-05-06",{"date":35,"type":20},"2027-01",{"name":37,"class":38},"Becton, Dickinson and Company","INDUSTRY",4,{"id":41,"slug":42,"hasResults":11,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":4,"eligibilityCriteria":46,"healthyVolunteers":11,"sex":47,"minAge":17,"maxAge":4,"enrollmentInfo":48,"targetDuration":4,"studyType":50,"phases":51,"briefSummary":53,"conditions":54,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},"100609591","the-continuity-study-100609591","NCT07216573","The Continuity Study","Continuous Blood Pressure Monitoring During Outpatient Surgery","Inclusion Criteria:\n\n1. Signed informed consent\n2. Age ≥ 18 years\n3. American Society of Anesthesiologists (ASA) Physical Status ≥ 2\n4. Scheduled for elective noncardiac surgery with intermittent arterial blood pressure monitoring using oscillometric arm cuff\n\nExclusion Criteria:\n\n1. Patient who is known to be pregnant\n2. Patient with existing or planned arterial pressure catheter\n3. Patient in whom systolic arterial pressure differs by more than 20 mmHg between the right and left arms\n4. Inability to place oscillometric cuff on the subject's upper extremity\n5. Extreme contraction of the smooth muscle in the arteries and arterioles of the lower arm and hand, such as may be present in patients with Raynaud's disease\n6. Finger or hand deformity that prevents proper placement of finger cuff by visual inspection\n7. Inability to place finger cuffs due to subject anatomy, condition, or obstructive paraphernalia (such as false nails)","ALL",{"count":49,"type":20},188,"INTERVENTIONAL",[52],"NA","A before and after interventional cohort study comparing intermittent blood pressure measurement using the oscillometric arm cuff to continuous noninvasive blood pressure (cNIBP) measurement using the VitaWave finger cuffs in subjects undergoing elective surgery in an outpatient setting.",[55],"Blood Pressure","2026-07-06",{"date":58,"type":31},"2026-07-08",{"date":60,"type":31},"2026-05-07",{"date":62,"type":20},"2027-02",{"name":37,"class":38},1,{"id":66,"slug":67,"hasResults":11,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":4,"eligibilityCriteria":71,"healthyVolunteers":11,"sex":47,"minAge":72,"maxAge":4,"enrollmentInfo":73,"targetDuration":4,"studyType":50,"phases":75,"briefSummary":76,"conditions":77,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":78,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":82,"locationsCount":64},"100553950","personal-bp---cai-study-100553950","NCT06492746","Personal BP - CAI Study","Assessing for Personalized Blood Pressure Targets During Cardiopulmonary Bypass With the Proprietary Cerebral Adaptive Index: A Pilot Investigation","Inclusion Criteria:\n\n1. Signed informed consent\n2. Age ≥ 45 years\n3. Planned cardiac surgery with Cardiopulmonary Bypass (CPB)\n4. Planned monitoring with ForeSight sensor and HemoSphere monitor\n5. Planned arterial catheterization for blood pressure monitoring\n6. High risk for cerebral vascular disease, defined as: a history of hypertension, pulse pressure \\> 60 mmHg, diabetes, stroke, transient ischemic attack, carotid bruit, tobacco smoking, or peripheral vascular disease\n\nExclusion Criteria:\n\n1. Non-English speaking\n2. Confirmed to be pregnant\n3. Surgery for congenital heart defect\n4. Non-availability of HemoSphere with laptop CAI interface","45 Years",{"count":74,"type":20},120,[52],"A single-center, prospective, observational pilot of the Cerebral Adaptive Index for assessing personalized blood pressure targets",[55],{"date":58,"type":31},{"date":80,"type":31},"2024-06-03",{"date":35,"type":20},{"name":37,"class":38},""]